{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:04:57Z","timestamp":1763748297258,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.msard.2021.102747","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T01:07:01Z","timestamp":1610586421000},"page":"102747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Cancer diagnosis in a Spanish cohort of multiple sclerosis patients under dimethylfumarate treatment"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4009-4561","authenticated-orcid":false,"given":"Mayra","family":"G\u00f3mez-Moreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria Gal\u00e1n","family":"S\u00e1nchez-Seco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Moreno-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula Salgado","family":"C\u00e1mara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Sabin-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9354-9101","authenticated-orcid":false,"given":"Lucia","family":"Ayuso-Peralta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia","family":"Oreja-Guevara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1701-1518","authenticated-orcid":false,"given":"Judit","family":"D\u00edaz-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8605-0049","authenticated-orcid":false,"given":"Susana","family":"Sainz de la Maza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucienne","family":"Costa-Frossard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bel\u00e9n","family":"Pilo de la Fuente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9459-5452","authenticated-orcid":false,"given":"Yolanda","family":"Aladro-Benito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.msard.2021.102747_bib0001","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12022-017-9502-7","article-title":"Hobnail variant of papillary thyroid carcinoma: a literature review","author":"Ambrosi","year":"2017","journal-title":"Endocrine Pathol.28"},{"issue":"9648","key":"10.1016\/j.msard.2021.102747_bib0002","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2021.102747_bib0003","first-page":"343","article-title":"The clinical course of multiple sclerosis","author":"Confavreux","year":"2014","journal-title":"Handb. Clin. Neurol.122"},{"key":"10.1016\/j.msard.2021.102747_bib0004","first-page":"89195","article-title":"Regulatory T cells and human disease","author":"Cools","year":"2007","journal-title":"Clin. Dev. Immunol.2007"},{"key":"10.1016\/j.msard.2021.102747_bib0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3389\/fneur.2019.00337","article-title":"Cancer risk and multiple sclerosis: evidence from a large Italian Cohort","author":"D\u2019Amico","year":"2019","journal-title":"Front. Neurol.10"},{"key":"10.1016\/j.msard.2021.102747_bib0006","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev-pharmtox-010818-021856","article-title":"Modulating NRF2 in disease: timing is everything","author":"Dodson","year":"2019","journal-title":"Ann. Rev. Pharmacol. Toxicol.59"},{"issue":"23","key":"10.1016\/j.msard.2021.102747_bib0007","doi-asserted-by":"crossref","first-page":"8226","DOI":"10.1158\/1078-0432.CCR-05-2035","article-title":"The therapeutic implications of intratumoral regulatory T cells","volume":"11","author":"Dranoff","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.msard.2021.102747_bib0008","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","article-title":"Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis","author":"Fox","year":"2012","journal-title":"N. Engl. J. Med.367"},{"key":"10.1016\/j.msard.2021.102747_bib0009","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jns.2016.09.005","article-title":"Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer risk","author":"Gaindh","year":"2016","journal-title":"J. Neurol. Sci.370"},{"key":"10.1016\/j.msard.2021.102747_bib0010","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420915005","article-title":"Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years\u2019 follow-up of DEFINE, CONFIRM, and ENDORSE","author":"Gold","year":"2020","journal-title":"Therap. Adv. Neurol. Disord.13"},{"issue":"2","key":"10.1016\/j.msard.2021.102747_bib0011","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/1352458516649037","article-title":"Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study","author":"Gold","year":"2017","journal-title":"Mult. Scler.23"},{"issue":"12","key":"10.1016\/j.msard.2021.102747_bib0012","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","author":"Gold","year":"2012","journal-title":"N. Engl. J. Med.367"},{"key":"10.1016\/j.msard.2021.102747_bib0013","doi-asserted-by":"crossref","unstructured":"Grytten, N., Myhr, K.M., Celius, E.G., Benjaminsen, E., Kampman, M., Midgard, R., Vatne, A., Aarseth, J.H., Riise, T., Torkildsen, O., 2019. Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study. Multiple sclerosis, 1352458519877244.","DOI":"10.1177\/1352458519877244"},{"key":"10.1016\/j.msard.2021.102747_bib0014","doi-asserted-by":"crossref","unstructured":"Handel, A.E., Ramagopalan, S.V., 2010. Multiple sclerosis and risk of cancer: a meta-analysis. J. Neurol. Neurosurg. Psychiatry81(12), 1413-1414.http:\/\/observatorio.aecc.es\/#datos-informes.https:\/\/seom.org\/images\/SEOM_cifras_cancer_2019.pdf.","DOI":"10.1136\/jnnp.2009.195776"},{"issue":"Pt 10","key":"10.1016\/j.msard.2021.102747_bib0017","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1093\/brain\/aws148","article-title":"Cancer risk in multiple sclerosis: findings from British Columbia, Canada","author":"Kingwell","year":"2012","journal-title":"Brain J. Neurol.135"},{"issue":"2","key":"10.1016\/j.msard.2021.102747_bib0018","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000504804","article-title":"Causes that contribute to the excess mortality risk in multiple sclerosis: a population-based study","volume":"54","author":"Kingwell","year":"2020","journal-title":"Neuroepidemiology"},{"issue":"10","key":"10.1016\/j.msard.2021.102747_bib0019","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s40263-018-0564-y","article-title":"Cancer risk in patients with multiple sclerosis: potential impact of disease-modifying drugs","volume":"32","author":"Lebrun","year":"2018","journal-title":"CNS Drugs"},{"issue":"Pt 3","key":"10.1016\/j.msard.2021.102747_bib0020","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","article-title":"Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway","author":"Linker","year":"2011","journal-title":"Brain J. Neurol.134"},{"issue":"3","key":"10.1016\/j.msard.2021.102747_bib0021","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/1352458514564489","article-title":"A systematic review of the incidence and prevalence of cancer in multiple sclerosis","author":"Marrie","year":"2015","journal-title":"Mult. Scler.21"},{"key":"10.1016\/j.msard.2021.102747_bib0022","first-page":"2954","article-title":"Multiple sclerosis and cancer: the Ying-Yang effect of disease modifying therapies","author":"Melamed","year":"2019","journal-title":"Front. Immunol.10"},{"issue":"6","key":"10.1016\/j.msard.2021.102747_bib0023","first-page":"411","article-title":"Multiple sclerosis and cancer in Norway. A retrospective cohort study","author":"Midgard","year":"1996","journal-title":"Acta Neurol. Scand.93"},{"issue":"3","key":"10.1016\/j.msard.2021.102747_bib0024","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0404.1991.tb04941.x","article-title":"Cancer incidence following hospitalization for multiple sclerosis in Denmark","author":"Moller","year":"1991","journal-title":"Acta Neurol. Scand.84"},{"issue":"2","key":"10.1016\/j.msard.2021.102747_bib0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1352458517751049","article-title":"ECTRIMS\/EAN Guideline on the pharmacological treatment of people with multiple sclerosis","author":"Montalban","year":"2018","journal-title":"Mult. Scler.24"},{"issue":"2","key":"10.1016\/j.msard.2021.102747_bib0026","first-page":"192","article-title":"Leiomyoma: its variants and secondary changes a five-year study","volume":"31","author":"Naz","year":"2019","journal-title":"J. Ayub Medical College, Abbottabad: JAMC"},{"issue":"1","key":"10.1016\/j.msard.2021.102747_bib0027","first-page":"1","article-title":"Prognostically favorable \u201cmitotically active\u201d smooth-muscle tumors of the uterus. A clinicopathologic study of ten cases","author":"Perrone","year":"1988","journal-title":"Am. J. Surg. Pathol.12"},{"issue":"8","key":"10.1016\/j.msard.2021.102747_bib0028","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s00415-020-09848-7","article-title":"Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population","author":"Sabin","year":"2020","journal-title":"J. Neurol.267"},{"issue":"3","key":"10.1016\/j.msard.2021.102747_bib0029","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1158\/1535-7163.MCT-16-0405","article-title":"Dimethyl fumarate controls the NRF2\/DJ-1 axis in cancer cells: therapeutic applications","volume":"16","author":"Saidu","year":"2017","journal-title":"Mol. Cancer Therap."},{"issue":"5","key":"10.1016\/j.msard.2021.102747_bib0030","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/med.21567","article-title":"Dimethyl fumarate, a two-edged drug: Current status and future directions","author":"Saidu","year":"2019","journal-title":"Med. Res. Rev.39"},{"key":"10.1016\/j.msard.2021.102747_bib0031","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.18.1.423","article-title":"Regulatory T cells in autoimmmunity*","author":"Shevach","year":"2000","journal-title":"Ann. Rev. Immunol.18"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821000134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821000134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:53:31Z","timestamp":1761900811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821000134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":29,"alternative-id":["S2211034821000134"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.102747","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer diagnosis in a Spanish cohort of multiple sclerosis patients under dimethylfumarate treatment","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.102747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102747"}}